We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Protein Profile Identified in Blood of Chronic Sinusitis Sufferers

By Labmedica staff writers
Posted on 23 Apr 2008
A protein profile identified in the blood of chronic sinusitis sufferers will help physicians to diagnose and treat the disease.

Scientists analyzed protein expression in the blood using surface enhanced laser desorption ionization time-of-flight mass spectroscopy (SELDI-TOF-MS). More...
They found that among 96 chronic sinusitis patients that there was a protein profile missing in 38 healthy controls. The test is about 88% accurate.

"We can diagnose this disease with a totally objective test that does not depend on symptoms or observations,” said Dr. Stilianos E. Kountakis, vice chair of the department of otolaryngology-head and neck surgery in the Medical College of Georgia School of Medicine (MCG; Augusta, GA, USA). He is corresponding author on the study published in the March/April 2008 issue of the American Journal of Rhinology.

To be classified chronic, sinusitis has to continue for at least 12 weeks. Causes include bacterial infections, respiratory inflammation, sinus polyps, and mucosal disease. Some causes, such as polyps and asthma, have a genetic predisposition. "You may have a bacterial infection, allergies, mechanical problems,” Dr. Kountakis said. "There are numerous genes that control respiratory function. Any of these things can go wrong to predispose the patient to develop chronic sinusitis.”

Diagnosing this chronically irritating disease, characterized by dripping noses, sinus pressure, congestion, and difficulty in breathing, is currently rather subjective. Patients describe their symptoms and doctors look at their sinuses with an endoscope and sometimes a computerized tomography scan. "… Overall management of [chronic sinusitis] is still hampered by the lack of quantifiable, molecular, and genetic markers to aid in screening,” the scientists wrote.


Related Links:
Medical College of Georgia School of Medicine

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Radiation Safety Barrier
RayShield Intensi-Barrier
Pressure Guidewire
SavvyWire
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.